| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner | President &CEO
1 company
Mohan Pankaj is a Director, 10% Owner at Outlook Therapeutics, Inc.. Recent SEC Form 4 filings include 1 buy and 4 sells.
Estimated insider holdings value: $11.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 15, 2019 | OTLK Outlook Therapeutics, Inc. | Director, 10% Owner | Buy | 8,000 | $0.68 | $5,440.00 | +0.1% | |
| Jan 4, 2018 | OTLK Outlook Therapeutics, Inc. | President &CEO | Sell | 114,677 | $1.17 | $134,067.48 | -0.8% | |
| Dec 19, 2017 | OTLK Outlook Therapeutics, Inc. | President &CEO | Sell | 104,131 | $1.15 | $119,325.03 | -0.7% |